Track PT Metro Healthcare Indonesia Tbk's EBIT ($120B) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Sep 30, 2026
Trailing 12 months ending Sep 30, 2026
PT Metro Healthcare Indonesia Tbk (CARE.JK) currently reports a EBIT of $120B as of September 2026. That compares with $66B in the prior-year period — up 76.7% year over year. That is below the sector sector average of $2.4T. Use the charts on this page to explore PT Metro Healthcare Indonesia Tbk's EBIT history and peer comparisons.
PT Metro Healthcare Indonesia Tbk's EBIT increased from $66B to $120B — a 76.7% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
PT Metro Healthcare Indonesia Tbk's EBIT of $120B is lower than the its sector sector average of $2.4T. That is roughly 95.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
PT Metro Healthcare Indonesia Tbk reported $120B in EBIT as of September 2026. That compares with $66B in the prior-year period — up 76.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current EBIT of $120B, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $2.4T. From there, open related valuation or income-statement pages for PT Metro Healthcare Indonesia Tbk, and consider following CARE.JK for alerts when major investors trade the stock.